Maryam Mazaheri is Director of CMC Operations at I-MAB Biopharma, with more than 18 years of experience in the pharmaceutical industry. She has led multiple early, late stage and commercial biological projects in small, medium, and large size companies. Her passion for Visual Inspection ignited in 2007 when she started coordinating a team to design, develop, standardize, and validate visual inspection methods in Medimmune. She has done an extensive amount of work in developing semi-quantitative methods for monitoring small inherent visible particles during product development. She also has been coordinator and active member of the Global Visual Inspection Workstream supported by EFPIA, working with different pharmaceutical companies to assemble knowledge and provide guidance in regard to new emerging visual inspection challenges in biologics.